Nonalcoholic steatohepatitis: risk factors for liver fibrosis

被引:66
|
作者
Shimada, M [1 ]
Hashimoto, E [1 ]
Kaneda, H [1 ]
Noguchi, S [1 ]
Hayashi, N [1 ]
机构
[1] Tokyo Womens Med Coll, Inst Gastroenterol, Tokyo, Japan
关键词
nonalcoholic steatohepatitis; liver fibrosis; liver cirrhosis; steatohepatitis; Mallory body;
D O I
10.1016/S1386-6346(02)00246-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of this study was to clarify the clinicopathological features of nonalcoholic steatohepatitis (NASH) and identify risk factors for severe hepatic fibrosis. Materials and Methods: Eighty-one patients with biopsy-proven NASH were studied. In all patients, the diagnosis of NASH was established on the basis of following criteria: (1) the presence of steatosis, lobular inflammation, and ballooning degeneration on liver biopsy, (2) intake of less than 20 g of ethanol per week, and (3) appropriate exclusion of other liver diseases. Results: The median age was 54 years (range: 21-82 years) and 41 patients were women (51%). Obesity was present in 58 patients (72%), while 25 patients (31%) had diabetes mellitus and 33 patients (41%) had hyperlipidemia. Histologically, 58 patients (72%) had trivial to moderate fibrosis, 6 patients (7%) had bridging fibrosis, and 17 patients (21%) had established cirrhosis. Multiple logistic regression analysis assessed clinical, laboratory and histological factors showed that the risk factors for fibrosis were a low platelet count (P = 0.0016), a high AST/ALT ratio (P = 0.0229), and the presence of Mallory bodies (P = 0.0209). To exclude factors that were a consequence of liver cirrhosis, variables included in the multiple logistic analysis were age, gender, diabetes, obesity, and hyperlipidemia. This showed that older age (P=0.0037) and the absence of hyperlipidemia (P = 0.0150) were risk factors for fibrosis. Conclusions: We found that a low platelet count, a high AST/ALT ratio, and the presence of Mallory bodies were significant predictors of severe liver fibrosis. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 50 条
  • [31] Clinical and Histologic Characterization of Steatotic HCV Liver Biopsy: Central Portalization Correlates with Fibrosis but Not with Risk Factors for Nonalcoholic Steatohepatitis (NASH)
    Lee, H.
    Dresser, K.
    Kurian, E. M.
    LABORATORY INVESTIGATION, 2014, 94 : 424A - 424A
  • [32] Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
    Dongiovanni, Paola
    Romeo, Stefano
    Valenti, Luca
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [33] Fibrogenesis and fibrosis in nonalcoholic steatohepatitis
    Di Rocco, P
    Costanzo, M
    Miele, L
    Forgione, A
    Alfei, B
    Rapaccini, G
    Grieco, A
    Gasbarrini, G
    GASTROENTEROLOGY, 2002, 122 (04) : A673 - A673
  • [34] Fibrosis in alcoholic and nonalcoholic steatohepatitis
    Bataller, Ramon
    Rombouts, Krista
    Altamirano, Jose
    Marra, Fabio
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2011, 25 (02) : 231 - 244
  • [35] Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020
    Kalligeros, Markos
    Vassilopoulos, Stephanos
    Vassilopoulos, Athanasios
    Shehadeh, Fadi
    Lazaridou, Ingrid
    Mylonakis, Eleftherios
    Promrat, Kittichai
    Wands, Jack R.
    ANNALS OF GASTROENTEROLOGY, 2023, 36 (06): : 670 - +
  • [36] Central Portalization Correlates with Fibrosis but Not with Risk Factors for Nonalcoholic Steatohepatitis in Steatotic Chronic Hepatitis C
    Lee, Hwajeong
    Ainechi, Sanaz
    Dresser, Karen
    Kurian, Elizabeth M.
    INTERNATIONAL JOURNAL OF HEPATOLOGY, 2014, 2014
  • [37] Family History of Diabetes and Risk of Nonalcoholic Steatohepatitis and Hepatic Fibrosis
    Loomba, Rohit
    Abraham, Maria
    Unalp-Arida, Aynur
    Wilson, Laura
    Lavine, Joel E.
    Doo, Edward
    Bass, Nathan M.
    GASTROENTEROLOGY, 2011, 140 (05) : S987 - S988
  • [38] Characterization of nonalcoholic steatohepatitis in obesity: Identification of risk factors for fibrotic liver disease.
    Monzon, CG
    Martin, E
    Larra-aga, E
    Lo Iacono, O
    Majano, P
    Bermejo, MF
    Sanz, P
    Otero, RM
    HEPATOLOGY, 1999, 30 (04) : 439A - 439A
  • [39] RISK AND PROTECTIVE FACTORS FOR NONALCOHOLIC STEATOHEPATITIS AND NONALCOHOLIC FATTY LIVER DISEASE IN A INFLAMMATORY BOWEL DISEASE PATIENT COHORT
    Cahill, Jennifer
    Martin, Brendan
    Venu, Mukund
    Asamoah, Nikiya
    Shastri, Nikhil
    Gupta, Neil
    Naik, Amar S.
    GASTROENTEROLOGY, 2018, 154 (06) : S628 - S628
  • [40] Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation
    Miyaaki, Hisamitsu
    Miuma, Satoshi
    Taura, Naota
    Shibata, Hidetaka
    Sasaki, Ryu
    Soyama, Akihiko
    Hidaka, Masaaki
    Takatsuki, Mitsuhisa
    Eguchi, Susumu
    Nakao, Kazuhiko
    TRANSPLANTATION, 2019, 103 (01) : 109 - 112